Financial reports
10-Q
2024 Q1
Quarterly report
8 Feb 24
ARS
2023 FY
Annual report to shareholders
17 Jan 24
10-K
2023 FY
Annual report
21 Nov 23
10-Q
2023 Q3
Quarterly report
8 Aug 23
10-Q
2023 Q2
Quarterly report
9 May 23
10-Q
2023 Q1
Quarterly report
7 Feb 23
ARS
2022 FY
Annual report to shareholders
18 Jan 23
10-K
2022 FY
Annual report
22 Nov 22
10-Q
2022 Q3
Quarterly report
9 Aug 22
10-Q
2022 Q2
Quarterly report
9 May 22
Current reports
8-K
Pathward Financial, Inc. Declares Cash Dividend
29 Feb 24
8-K
Pathward Appoints Neeraj Mehta To Board Of Directors
28 Feb 24
8-K
Regulation FD Disclosure
13 Feb 24
8-K
Pathward Financial, Inc. Announces Results for 2024 Fiscal First Quarter
24 Jan 24
8-K
Pathward Financial, Inc. Declares Cash Dividend
16 Nov 23
8-K
Regulation FD Disclosure
7 Nov 23
8-K
Pathward Financial, Inc. Announces Results for 2023 Fiscal Fourth Quarter and Fiscal Year 2023
25 Oct 23
8-K
Pathward Appoints Greg Sigrist as Next Chief Financial Officer
5 Oct 23
8-K
Investor Presentation UPDATED SEPTEMBER 6 , 2023
6 Sep 23
8-K
Pathward Financial, Inc. Announces Authorization of Common Stock Share Repurchase Program and Cash Dividend for Fourth Fiscal Quarter of 2023
25 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
28 Feb 24
424B3
Prospectus supplement
20 Jan 23
D
$20.00 mm in debt, sold $20.00 mm, 11 investors
7 Oct 22
S-3ASR
Automatic shelf registration
28 Sep 21
425
Business combination disclosure
16 May 18
424B3
Prospectus supplement
27 Apr 18
S-4
Registration of securities issued in business combination transactions
19 Mar 18
Proxies
DEFA14A
Additional proxy soliciting materials
17 Jan 24
DEF 14A
Definitive proxy
17 Jan 24
DEFA14A
Additional proxy soliciting materials
18 Jan 23
DEF 14A
Definitive proxy
18 Jan 23
DEFA14A
Additional proxy soliciting materials
13 Jan 22
DEF 14A
Definitive proxy
13 Jan 22
DEFA14A
Additional proxy soliciting materials
14 Jan 21
DEF 14A
Definitive proxy
14 Jan 21
DEFA14A
Additional proxy soliciting materials
15 Jan 20
DEF 14A
Definitive proxy
15 Jan 20
Other
EFFECT
Notice of effectiveness
23 Jan 23
CORRESP
Correspondence with SEC
18 Jan 23
UPLOAD
Letter from SEC
20 Dec 22
EFFECT
Notice of effectiveness
30 Apr 18
CORRESP
Correspondence with SEC
26 Apr 18
CORRESP
Correspondence with SEC
20 Apr 18
EFFECT
Notice of effectiveness
12 Jul 16
CORRESP
Correspondence with SEC
8 Jul 16
UPLOAD
Letter from SEC
5 Jul 16
EFFECT
Notice of effectiveness
16 Mar 16
Ownership
4
Anthony M. Sharett
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
Jennifer W. Warren
5 Mar 24
4
Charles C. Ingram
5 Mar 24
4
Nadia Dombrowski
5 Mar 24
4
Greg Sigrist
5 Mar 24
4
Anthony M. Sharett
5 Mar 24
4
Brett L. Pharr
5 Mar 24
4
Kendall E Stork
5 Mar 24
4
Christopher Perretta
5 Mar 24